GNRH1 and breast carcinoma: In a study involving 100 patients with ER-breast cancer, no difference was observed in menstruation resumption rates between the GnRH and control groups (both 80%, p = 1.00) at 12 months after completing cyclophosphamide-based chemotherapy [55].